Portfolio company
Marginum
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company manufactures fluorescence-based tissue monitoring devices for surgeons to identify cancerous cells in surgical suction waste during oncological procedures.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Refined Diagnostics
This company develops AI-powered laser imaging systems for real-time, stain-free tissue analysis and cancer diagnostics for surgeons, pathologists, and hospitals.
Neurolase
This company develops a handheld laser device using artificial intelligence to help neurosurgeons identify cancerous brain tissue in real time during surgery.
Fluolink
Fluolink develops optical guidance systems and fluorescence spectroscopy sensors for neurosurgeons to identify brain tumours and cerebral microcirculation during surgical procedures.
SamanTree Medical
This company develops digital microscopy scanners for surgeons and pathologists to perform real-time assessment of fresh tissue samples during cancer surgery.
Lightpoint
This company develops miniaturised imaging and sensing tools for intra-operative cancer detection to assist surgeons during robot-assisted procedures.
SepsiScan
This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.
SURGAR
This company develops augmented reality software for surgeons to visualize internal organ structures during minimally invasive surgery.
AIMAGO SA
This company develops medical imaging technology to visualise blood microcirculation for surgeons performing plastic and reconstructive procedures.
